Maines M D, Trakshel G M, Kutty R K
J Biol Chem. 1986 Jan 5;261(1):411-9.
The present report describes, for the first time, the identification of two constitutive forms of heme oxygenase, designated as HO-1 and HO-2, in rat liver microsomal fractions. HO-1 was purified to homogeneity and exhibited a specific activity of up to 4000 nmol of bilirubin/mg of protein/h. HO-2 was partially purified to a specific activity of 250 nmol of bilirubin/mg of protein/h. In the native state, the relative activity of HO-2 surpassed that of HO-1 by 2-3-fold. However, a remarkable difference existed in the regulatory mechanism(s) for the production of the two enzyme forms. Whereas the activity of HO-1 was increased up to 100-fold in response to cobalt, cadmium, hematin, phenylhydrazine, and bromobenzene, that of HO-2 was fully refractory to these agents. The two forms differed in their apparent Km, thermolability, ammonium sulfate precipitation, antigenicity, electrophoretic mobility under nondenaturing conditions, and chromatographic behavior. Specifically, for HO-1 the apparent Km value was 0.24 microM, whereas that for HO-2 was 0.67 microM. HO-2 preparation was more susceptible to heat inactivation; nearly 65% activity was retained by HO-1 preparation after exposure to 60 degrees C for 10 min, whereas under the same conditions only about 25% of HO-2 activity was retained. When subjected to ammonium sulfate precipitation the bulk of HO-1 activity precipitated between 0 and 35% saturation, whereas that of HO-2 was precipitated between 35 and 65% saturation. The two forms appeared as immunologically different entities, in so far as a crossreactivity between antibody raised against HO-1 in rabbit and HO-2 could not be detected. Similarities were observed in respect to cofactor requirements for activity, sensitivity to inhibitors, as well as their reactivity towards the substrates used in this study, i.e. hematin, hematoheme, and cytochrome c. Specifically both forms of the enzyme required NADPH-cytochrome c (P-450) reductase, NADPH or NADH, and O2 for activity, and reactions were inhibited by KCN, NaN3, and CO. Both forms cleaved the tetrapyrrole molecule exclusively at the alpha-meso bridge to form biliverdin IX alpha isomer. HO-1 and HO-2 utilized hematin and hematoheme as substrates but not intact cytochrome c.
本报告首次描述了在大鼠肝脏微粒体组分中鉴定出两种组成型血红素加氧酶,分别命名为HO - 1和HO - 2。HO - 1被纯化至同质,其比活性高达每毫克蛋白质每小时4000纳摩尔胆红素。HO - 2被部分纯化,比活性为每毫克蛋白质每小时250纳摩尔胆红素。在天然状态下,HO - 2的相对活性比HO - 1高2至3倍。然而,两种酶形式产生的调节机制存在显著差异。HO - 1的活性在钴、镉、血晶素、苯肼和溴苯的作用下可增加至100倍,而HO - 2的活性对这些试剂完全不敏感。两种形式在表观Km、热稳定性、硫酸铵沉淀、抗原性、非变性条件下的电泳迁移率以及色谱行为方面存在差异。具体而言,HO - 1的表观Km值为0.24微摩尔,而HO - 2的表观Km值为0.67微摩尔。HO - 2制剂更容易受热失活;HO - 1制剂在60℃下暴露10分钟后仍保留近65%的活性,而在相同条件下,HO - 2仅保留约25%的活性。当进行硫酸铵沉淀时,大部分HO - 1活性在饱和度0至35%之间沉淀,而HO - 2的活性在饱和度35至65%之间沉淀。两种形式在免疫学上表现为不同的实体,因为在兔体内针对HO - 1产生的抗体与HO - 2之间未检测到交叉反应性。在活性的辅因子需求、对抑制剂的敏感性以及它们对本研究中使用的底物(即血晶素、血红素和细胞色素c)的反应性方面观察到相似之处。具体而言,两种酶形式都需要NADPH - 细胞色素c(P - 450)还原酶、NADPH或NADH以及O2来发挥活性,并且反应受到KCN、NaN3和CO的抑制。两种形式都仅在α - 中桥处裂解四吡咯分子以形成胆绿素IXα异构体。HO - 1和HO - 2利用血晶素和血红素作为底物,但不利用完整的细胞色素c。